{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:43:36Z","timestamp":1782920616040,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1067\/mjd.2000.104680","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:22:26Z","timestamp":1027570946000},"page":"24-30","source":"Crossref","is-referenced-by-count":63,"special_numbering":"P1","title":["Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria"],"prefix":"10.1067","volume":"43","author":[{"given":"Ann K.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert F.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Schoenwetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.104680_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199506293322608","article-title":"Chronic urticaria","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.104680_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2133.1997.tb14895.x","article-title":"The impact of chronic urticaria on quality of life","volume":"136","author":"O?Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.104680_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)?a simple, practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2000.104680_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2302\/kjm.46.37","article-title":"The pathogenesis of urticaria","volume":"46","author":"Kobza Black","year":"1997","journal-title":"Keio J Med"},{"key":"10.1067\/mjd.2000.104680_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bmj.316.7138.1147","article-title":"ABC of allergies: allergy and the skin. I: urticaria","volume":"316","author":"Greaves","year":"1998","journal-title":"Br Med J"},{"key":"10.1067\/mjd.2000.104680_bib6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0091-6749(05)80245-3","article-title":"Urticaria: current therapy","volume":"86","author":"Soter","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2000.104680_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1346-8138.1996.tb02694.x","article-title":"Histamine: the quintessential mediator","volume":"23","author":"Greaves","year":"1996","journal-title":"J Dermatol"},{"key":"10.1067\/mjd.2000.104680_bib8","first-page":"268","article-title":"Chronic urticaria","volume":"152","author":"Burrall","year":"1990","journal-title":"West J Med"},{"key":"10.1067\/mjd.2000.104680_bib9","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/S0091-6749(96)80116-3","article-title":"Clinical comparison of histamine H1-receptor antagonist drugs","volume":"98","author":"Du Buske","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2000.104680_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/09546639809160545","article-title":"Fexofenadine hydrochloride in the treatment of chronic idiopathic urticaria: a placebo-controlled, parallel group, dose-ranging study","volume":"9","author":"Paul","year":"1998","journal-title":"J Dermatol Treat"},{"key":"10.1067\/mjd.2000.104680_bib11","unstructured":"Data on file, Hoechst Marion Roussel, Kansas City, MO. Protocol PJPR0039: Nelson H, Fretwell R, Qu R, Long J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria."},{"key":"10.1067\/mjd.2000.104680_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria (CIU)","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mjd.2000.104680_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1067\/mjd.2000.104680_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2500\/108854195778667837","article-title":"Update on urticaria and angioedema (hives)","volume":"16","author":"Fox","year":"1995","journal-title":"Allergy Asthma Proc"},{"key":"10.1067\/mjd.2000.104680_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2000.104680_bib16","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/S0091-6749(96)80116-3","article-title":"Clinical comparison of histamine H1-receptor antagonist drugs","volume":"98","author":"Du Buske","year":"1996","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200651344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200651344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:25:04Z","timestamp":1557401104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200651344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0190962200651344"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.104680","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}